The immunoglobulin heavy chain variable region (IGHV) mutational status and the tumor protein p53 (TP53) gene have been the most important prognostic molecular markers in CLL for a long time [18,19,20,21,22]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.